|
1
|
Lazcano-Ponce EC, Miquel JF, Muñoz N,
Herrero R, Ferrecio C, Wistuba II, de Ruiz Alonso P, Urista Aristi
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sheth S, Bedford A and Chopra S: Primary
gallbladder cancer: Recognition of risk factors and the role of
prophylactic cholecystectomy. Am J Gastroenterol. 95:1402–1410.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Levy AD, Murakata LA and Rohrmann CA Jr:
Gallbladder carcinoma: Radiologic-pathologic correlation.
Radiographics. 21:295–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schroeder M and Mass MJ: CpG methylation
inactivates the transcriptional activity of the promoter of the
human p53 tumor suppressor gene. Biochem Biophys Res Commun.
235:403–406. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rizvi MM, Alam MS, Ali A, Mehdi SJ, Batra
S and Mandal AK: Aberrant promoter methylation and inactivation of
PTEN gene in cervical carcinoma from Indian population. J Cancer
Res Clin Oncol. 137:1255–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oshimo Y, Nakayama H, Ito R, Kitadai Y,
Yoshida K, Chayama K and Yasui W: Promoter methylation of cyclin D2
gene in gastric carcinoma. Int J Oncol. 23:1663–1670.
2003.PubMed/NCBI
|
|
7
|
Mazieres J, He B, You L, Xu Z, Lee AY,
Mikami I, Reguart N, Rosell R, McCormick F and Jablons DM: Wnt
inhibitory factor-1 is silenced by promoter hypermethylation in
human lung cancer. Cancer Res. 64:4717–4720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen T and Li E: Structure and function of
eukaryotic DNA methyltransferases. Curr Top Dev Biol. 60:55–89.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ai L, Tao Q, Zhong S, Fields CR, Kim WJ,
Lee MW, Cui Y, Brown KD and Robertson KD: Inactivation of Wnt
inhibitory factor-1 (WIF1) expression by epigenetic silencing is a
common event in breast cancer. Carcinogenesis. 27:1341–1348. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazieres J, He B, You L, Xu Z, Lee AY,
Mikami I, Reguart N, Rosell R, McCormick F and Jablons DM: Wnt
inhibitory factor-1 is silenced by promoter hypermethylation in
human lung cancer. Cancer Res. 64:4717–4720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramachandran I, Thavathiru E, Ramalingam
S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A,
Anant S and Queimado L: Wnt inhibitory factor 1 induces apoptosis
and inhibits cervical cancer growth, invasion and angiogenesis in
vivo. Oncogene. 31:2725–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Y, Du Q, Wu W, She F and Chen Y:
Rescued expression of WIF-1 in gallbladder cancer inhibits tumor
growth and induces tumor cell apoptosis with altered expression of
proteins. Mol Med Rep. 14:2573–2581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dérijard B, Hibi M, Wu IH, Barrett T, Su
B, Deng T, Karin M and Davis RJ: JNK1: A protein kinase stimulated
by UV light and Ha-Ras that binds and phosphorylates the c-Jun
activation domain. Cell. 76:1025–1037. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Behrens A, Sibilia M and Wagner EF:
Amino-terminal phosphorylation of c-Jun regulates stress-induced
apoptosis and cellular proliferation. Nat Genet. 21:326–329. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Behrens A, Jochum W, Sibilia M and Wagner
EF: Oncogenic transformation by ras and fos is mediated by c-Jun
N-terminal phosphorylation. Oncogene. 19:2657–2663. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schreiber M, Kolbus A, Piu F, Szabowski A,
Möhle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF: Control
of cell cycle progression by c-Jun is p53 dependent. Genes Dev.
13:607–619. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryan KM, Phillips AC and Vousden KH:
Regulation and function of the p53 tumor suppressor protein. Curr
Opin Cell Biol. 13:332–337. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vogt PK: Jun, the oncoprotein. Oncogene.
20:2365–2377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rice P, Longden I and Bleasby A: EMBOSS:
The european molecular biology open software suite. Trends Genet.
16:276–277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bock C, Reither S, Mikeska T, Paulsen M,
Walter J and Lengauer T: BiQ Analyzer: Visualization and quality
control for DNA methylation data from bisulfite sequencing.
Bioinformatics. 21:4067–4068. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsieh JC, Kodjabachian L, Rebbert ML,
Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB and Nathans J:
A new secreted protein that binds to Wnt proteins and inhibits
their activities. Nature. 398:431–436. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li HP, Leu YW and Chang YS: Epigenetic
changes in virus-associated human cancers. Cell Res. 15:262–271.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Byun T, Karimi M, Marsh JL, Milovanovic T,
Lin F and Holcombe RF: Expression of secreted Wnt antagonists in
gastrointestinal tissues: Potential role in stem cell homeostasis.
J Clin Pathol. 58:515–519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smith LM, Birrer MJ, Stampfer MR and Brown
PH: Breast cancer cells have lower activating protein 1
transcription factor activity than normal mammary epithelial cells.
Cancer Res. 57:3046–3054. 1997.PubMed/NCBI
|
|
29
|
Kharman-Biz A, Gao H, Ghiasvand R, Zhao C,
Zendehdel K and Dahlman-Wright K: Expression of activator protein-1
(AP-1) family members in breast cancer. BMC cancer. 13:4412013.
View Article : Google Scholar : PubMed/NCBI
|
